Our data demonstrate that administration of gremlin siRNA plasmid to diabetic mice alleviated renal hypertrophy, cell proliferation and apoptosis, and subsequently suppressed collagen type IV accumulation and mesangial expansion, indicating beneficial effects of Gremlin inhibition on diabetic nephropathy. Here, GREM1 is linked to diabetic kidney disease.